antipsychotic 发表于 2025-3-30 12:05:26
https://doi.org/10.1007/978-3-642-90719-7iew is focused on recently discovered biomarkers with diagnostic, prognostic, histologic, and response prediction capacities. Yet none of the described biomarkers could be used instead of biopsy. A long road is ahead to reach the optimal biomarker profile with bedside utility.ingenue 发表于 2025-3-30 16:22:02
http://reply.papertrans.cn/19/1879/187815/187815_52.pngCIS 发表于 2025-3-30 19:53:25
http://reply.papertrans.cn/19/1879/187815/187815_53.pngEnliven 发表于 2025-3-30 21:29:11
http://reply.papertrans.cn/19/1879/187815/187815_54.pngAmbulatory 发表于 2025-3-31 01:40:42
http://reply.papertrans.cn/19/1879/187815/187815_55.pngVldl379 发表于 2025-3-31 09:03:00
http://reply.papertrans.cn/19/1879/187815/187815_56.png点燃 发表于 2025-3-31 12:21:11
http://reply.papertrans.cn/19/1879/187815/187815_57.pngExtemporize 发表于 2025-3-31 14:47:35
Apelin and Copeptin as Biomarkers of Kidney Disease,ior, modified by plasma osmolality, stress, and various disease states, revealing some of the various physiologic and pathophysiologic conditions associated with increased or decreased AVP..Apelin, belonging to a signaling pathway implicated in the regulation of cardiovascular function and fluid hom用手捏 发表于 2025-3-31 18:13:34
Biomarkers for Kidney Injury in Cystic Fibrosis,stimates true kidney function and does not detect kidney injury until a significant number of nephrons have been affected. Novel biomarkers, such as cystatin C (CysC), retinol-binding protein (RBP), kidney injury molecule-1 (KIM-1), and neutrophil gelatinase-associated lipocalin (NGAL) have been stuGRAVE 发表于 2025-3-31 22:08:10
Biomarkers in Focal Segmental Glomerulosclerosis,s proteomics, transcriptomics, metabolomics, and other related “omics” have brought the novel way of detection biomarkers in various diseases. In this review, we focus on the recently presented biomarkers for diagnosis, prognosis, and prediction of the responsiveness to drugs for FSGS detected by di